NCT04610229View on ClinicalTrials.gov

Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

August 12, 2019

Study Completion Date

August 26, 2019

Conditions
Glioblastoma MultiformeGlioblastomaGlioblastoma, Adult
Interventions
RADIATION

Hypofractionation guioded by dose painting

1

Trial Locations (1)

42123

Radiotherapy Unit Ausl Irccs Reggio Emilia, Reggio Emilia

All Listed Sponsors
lead

Azienda USL Reggio Emilia - IRCCS

OTHER_GOV

NCT04610229 - Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas. | Biotech Hunter | Biotech Hunter